Signatures guide drug choice

This publication has 10 references indexed in Scilit:

• BRAF mutation predicts sensitivity to MEK inhibition
  Nature, 2005
• Oncogenic pathway signatures in human cancers as a guide to targeted therapies
  Nature, 2005
• An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis
  Nature Genetics, 2004
• Targeting the mitogen-activated protein kinase cascade to treat cancer
  Nature Reviews Cancer, 2004
• Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression
  Genes & Development, 2004
• Microarray expression profiling in melanoma reveals a BRAF mutation signature
  Oncogene, 2004
• Gene expression phenotypic models that predict the activity of oncogenic pathways
  Nature Genetics, 2003
• Targeting RAS signalling pathways in cancer therapy
  Nature Reviews Cancer, 2003
• Addiction to Oncogenes--the Achilles Heal of Cancer
  Science, 2002
• Analysis of gene expression during myc oncogene-induced lymphomagenesis in the bursa of Fabricius
  Proceedings of the National Academy of Sciences, 2001